Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced process for D-tyrosine production using tartrate resolution. Offers superior cost efficiency and scalability for pharmaceutical intermediate manufacturing compared to enzymatic methods.
Patent CN113201516A details a novel P-nitrobenzyl esterase mutant for solvent-free L-menthol production, offering superior stereoselectivity and cost-effective manufacturing.
Patent CN102399139B details a scalable resolution method for Shikonin and Alkannin. Achieve >99% ee with cost-effective raw materials for API manufacturing.
Patent CN110423219A reveals aqueous resolution for high-purity R-tetrahydropapaverine. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN118255768A details high-purity Ruxolitinib synthesis via chiral resolution. Offers cost reduction in API manufacturing and scalable supply chain solutions.
Patent CN109553610A details a novel six-step synthesis for emtricitabine isomers offering high purity and scalable manufacturing processes for global supply chains.
Novel patent CN103664887B enables high-purity Esomeprazole Sodium production. Eliminating toxic solvents ensures cost reduction and supply chain reliability for global pharmaceutical partners.
Patent CN110467557A reveals a high-yield one-pot synthesis for Apremilast. This report analyzes cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN103214487A reveals stable synthesis route. Offers cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Novel preparation method for Silodosin intermediate via CN104974072A. Offers cost reduction and scalable manufacturing for pharmaceutical supply chains.
Patent CN106660949B reveals a safe, scalable chiral resolution method for TRPV1 antagonist intermediates, offering significant cost reduction in API manufacturing.
Novel asymmetric acetal method for (1R,5S)-3-ethylbicyclo[3.2.0]hept-3-en-6-one synthesis. High ee%, low cost, scalable process for API manufacturing.
Novel chiral resolution method for Tetrabenazine using di-p-methylbenzoyltartaric acid. Achieves >99% ee with scalable crystallization for reliable API intermediate supply.
Patent CN102850204B details advanced chiral resolution for NSAIDs. Discover cost-effective manufacturing and reliable supply chain solutions for high-purity intermediates.
Novel water-based resolution method for S-3-aminopiperidine. High purity 99.5% yield 72%. Cost-effective pharmaceutical intermediate supply chain solution.
Patent CN111909067B reveals a novel 5-step total synthesis of D-penicillamine from L-serine, offering high optical purity and scalable production for pharmaceutical supply chains.
Discover the advanced synthesis of (1S)-4,5-dimethoxy-1-[(methylamino)methyl]benzocyclobutane hydrochloride. A cost-effective, scalable route for pharmaceutical supply chains.
Discover a novel purification method for Indacaterol intermediates using m-chlorobenzoic acid, offering higher yield and purity for reliable API intermediate supply chains.
Novel resolution method using L-Tyrosine methyl ester achieves >99.5% ee. Cost-effective, scalable process for pharmaceutical intermediates.
Patent CN100473640C details a novel resolution method for trans-2,3-diamino-1,2,3,4-tetrahydronaphthalene using tartaric acid derivatives, offering high ee values and scalable manufacturing.